Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is an increase over the number of companies cited in the previous month.
The citations in the county were 'You offered food-producing animal(s) for interstate commerce that was found to bear or contain a drug residue in an edible tissue above an established safe level, safe concentration, or tolerance' and 'You did not review treatment records, prior to shipment of an animal for slaughter for human food, to assure that drugs have been used only as directed and that appropriate withdrawal periods have been met'.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Koopman Dairies, Inc. | Veterinary | 03/12/2025 | Introduction/delivery into IS - illegal drug residue |
| Koopman Dairies, Inc. | Veterinary | 03/12/2025 | Records review prior to shipment for slaughter |
Alerts Sign-up